Invesco Ltd. Aclaris Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.92 - $1.44 $1,066 - $1,668	-1,159 Reduced 3.66%	30,498 $37,000
Q4 2023 Feb 12, 2024	SELL	$0.64 - $6.49 $5,159 - $52,315	-8,061 Reduced 20.3%	31,657 $33,000
Q3 2023 Nov 13, 2023	SELL	$6.56 - $10.95 $5,582 - $9,318	-851 Reduced 2.1%	39,718 $272,000
Q2 2023 Aug 11, 2023	BUY	$7.89 - $10.64 $19,188 - $25,876	2,432 Added 6.38%	40,569 $420,000
Q1 2023 May 12, 2023	BUY	$7.07 - $17.95 $73,202 - $185,854	10,354 Added 37.27%	38,137 $308,000
Q4 2022 Feb 13, 2023	SELL	$14.33 - $18.37 $17,224 - $22,080	-1,202 Reduced 4.15%	27,783 $437,000
Q3 2022 Nov 14, 2022	BUY	$13.07 - $18.22 $55,103 - $76,815	4,216 Added 17.02%	28,985 $456,000
Q2 2022 Aug 15, 2022	BUY	$10.16 - $17.08 $7,040 - $11,836	693 Added 2.88%	24,769 $346,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $2,561 - $4,712	-263 Reduced 1.08%	24,076 $415,000
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $5.09 Million - $7.66 Million	-414,463 Reduced 94.45%	24,339 $354,000
Q3 2021 Nov 15, 2021	BUY	$13.38 - $18.8 $5.6 Million - $7.88 Million	418,886 Added 2103.26%	438,802 $7.9 Million
Q2 2021 Aug 17, 2021	SELL	$17.08 - $29.6 $15.2 Million - $26.3 Million	-887,118 Reduced 97.8%	19,916 $350,000
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $4.77 Million - $22.6 Million	813,562 Added 870.38%	907,034 $22.9 Million
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $10,716 - $30,774	-4,044 Reduced 4.15%	93,472 $605,000
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.71 $4,836 - $8,737	-3,224 Reduced 3.2%	97,516 $251,000
Q2 2020 Aug 14, 2020	SELL	$1.04 - $1.73 $14,577 - $24,249	-14,017 Reduced 12.21%	100,740 $163,000
Q1 2020 May 15, 2020	BUY	$0.75 - $2.18 $65,655 - $190,837	87,540 Added 321.64%	114,757 $119,000
Q4 2019 Feb 14, 2020	SELL	$1.02 - $1.97 $1,841 - $3,555	-1,805 Reduced 6.22%	27,217 $51,000
Q3 2019 Nov 14, 2019	SELL	$0.79 - $2.47 $900 - $2,815	-1,140 Reduced 3.78%	29,022 $31,000
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $2,283 - $7,568	-1,072 Reduced 3.43%	30,162 $66,000
Q1 2019 May 15, 2019	BUY	$5.63 - $7.84 $175,847 - $244,874	31,234 New	31,234 $187,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account